Accord Healthcare Ltd., is the offshore identity of Intas. A marketing arm of Intas, Accord is engaged in all the licensing related activities and pharmaceutical product trading in the regulatory markets. The company leverages the manufacturing support from Intas. Accord Healthcare has its global matrix spread to USA, UK, France, Italy, Spain, Canada, Brazil, Mexico, South Africa, New Zealand, Australia, Peru and Vietnam.

For more information, please visit www.accord-healthcare.com

Conceptualized with the objective of shaping the future of drug development, Astron Research Ltd. is a leading Pharmaceutical formulation research and development organization accredited by USFDA. It also has an MHRA approved testing laboratory in UK. Capabilities include dossier development, formulation and analytical research, Regulatory Affairs and Quality Assurance.

For more information, please visit www.astron-research.com

Intas Biopharmaceuticals Ltd. (IBPL), is one of the front runners in the biopharmaceuticals sector in India. To provide world-class services to clients in regulated and non-regulated markets, IBPL boasts the first EU approved state-of-the-art manufacturing facility in India for bulk and finished formulation (in pre-filled syringe) in conformity with stringent cGMP norms. Capabilities include manufacturing bio-recombinant and DNA based products and development of Ecoli and cell culture based technology. Intas Biopharmaceuticals Ltd. has also successfully developed and launched five products in Indian market.

For more information, please visit www.intasbiopharma.co.in

Intas Medi Devices Ltd. is a subsidiary of Intas Pharmaceutical Ltd., formed by a strategic tie-up with Turkey based Alvimedica Medical Technologies to market medical devices in India & Nepal. The company markets a wide range of products in Cardio Vascular, General Surgery and Gynecology / Urology.

For more information, please visit www.intas-medidevices.com